Seobin Yoon

Seobin Yoon

Auto-generated profile, based on publicly available information

Seobin Yoon

Department of Life Sciences, Chung-Ang University, Seoul 06974, South Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ECEui-Hwan Choi
Eui-Hwan Choi
SYSeobin Yoon
Seobin Yoon
KPKyung-Soon Park
Kyung-Soon Park
KKKeun P. Kim
Keun P. Kim
Embryonic stem (ES) cells require homologous recombination (HR) to cope with genomic instability caused during self-renewal. Here, we report expression dynamics and localization of endogenous HR factors in DNA break repair of ES cells. In addition, we analyzed gene expression patterns of HR-related factors at the transcript level with RNA-sequencing experiments. We showed that ES cells constitutively expressed diverse HR proteins throughout the cell cycle and that HR protein expression was not significantly changed even in the DNA damaging conditions. We further analyzed that depleting Rad51 resulted in the accumulation of larger single-stranded DNA (ssDNA) gaps, but did not perturb DNA replication, indicating that ES cells were able to enter the G2-phase in the presence of unrepaired DNA gaps, consistent with the possibility that post-replication repair helps avoid stalling at the G2/M checkpoint. Interestingly, caffeine treatment inhibited the formation of Rad51 or Rad54 foci, but not the formation of γH2AX and Exo1 foci, which led to incomplete HR in ssDNA, thus increasing DNA damage sensitivity. Our results suggested that ES cells possess conserved HR-promoting machinery to ensure effective recruitment of the HR proteins to DNA breaks, thereby driving proper chromosome duplication and cell cycle progression in ES cells.

31 January 2023 in BMB Reports
Verified
Journal Article
Open access
PDF file
SPSeo Jung Park
Seo Jung Park
SYSeobin Yoon
Seobin Yoon
ECEui-Hwan Choi
Eui-Hwan Choi
HHHana Hyeon
Hana Hyeon
KLKangseok Lee
Kangseok Lee
KKKeun Pil Kim
Keun Pil Kim
Seo Jung Park, Seobin Yoon, Eui-Hwan Choi, Hana Hyeon, Kangseok Lee & Keun Pil Kim. BMB Reports 2023;56:102-7. https://doi.org/10.5483/BMBRep.2022-0149

28 September 2023 in Phytomedicine
Verified
Journal Article
Open access
SYSeobin Yoon
Seobin Yoon
BLBum Kyu Lee
Bum Kyu Lee
KKKeun Pil Kim
Keun Pil Kim
Colorectal cancer (CRC) is one of the most common types of cancer. This disease arises from gene mutations and epigenetic alterations that transform colonic epithelial cells into colon adenocarcinoma cells, which display a unique gene expression pattern compared to normal cells. Specifically, CRC cells exhibit significantly higher expression levels of genes involved in DNA repair or replication, which is attributed to the accumulation of DNA breakage resulting from rapid cell cycle progression. This study aimed to investigate the in vivo effects of caffeine on CRC cells and evaluate its impact on the sensitivity of these cells to irinotecan, a topoisomerase I inhibitor widely used for CRC treatment. Two CRC cell lines, HCT116 and HT29, were treated with irinotecan and caffeine. Western blot analysis assessed protein expression levels in caffeine/irinotecan-treated CRC cells. Immunofluorescence staining determined protein localization, measured DNA breaks, and explored the effects of DNA damage reagents during cell cycle progression and flow cytometry analysis was used to measure cell viability. Fiber assays investigated DNA synthesis in DNA-damaged cells during S-phase, while the comet assay assessed DNA fragmentation caused by DNA breaks. Our findings demonstrated that the combination of irinotecan and caffeine exhibits a synergistic effect in suppressing CRC cell proliferation and inducing cell death. Compared to treatment with only irinotecan or caffeine, the combined irinotecan and caffeine treatment was more effective in inducing DNA lesions by displacing RAD51 from DNA break sites and inhibiting DNA repair progression, leading to cell cycle arrest. This combination also resulted in more severe effects, including DNA fragmentation and mitotic catastrophe. Caffeine could enhance the effectiveness of an existing drug for CRC treatment despite having little impact on the cell survival rate of CRC cells. Our findings suggest that the beneficial adjuvant effects of caffeine may not only be applicable to CRC but also to various other types of cancers at different stages of development.

1 February 2023 in BMB Reports
Verified
Journal Article
Open access
PDF file
SYSeobin Yoon
Seobin Yoon
ECEui-Hwan Choi
Eui-Hwan Choi
SPSeo Jung Park
Seo Jung Park
KKKeun Pil Kim
Keun Pil Kim
Seobin Yoon, Eui-Hwan Choi, Seo Jung Park & Keun Pil Kim. BMB Reports 2023;56:108-13. https://doi.org/10.5483/BMBRep.2022-0106